Matthew Windsor Goulding

Boston
  • 200 Clarendon Street
  • Boston, MA 02116
  • USA
 
 

Matt Goulding, Co-Chair of Latham's Boston Corporate Department, advises clients on a full spectrum of private equity transactions, along with general corporate matters.

Mr. Goulding represents financial sponsors, private companies, portfolio companies, boards of directors, founders, and management teams in connection with:

  • Leveraged buyouts
  • Joint ventures
  • Mergers and acquisitions
  • Shareholder arrangements
  • Carveout transactions
  • Take-privates 

He also works on equity syndication, fund formation, and general corporate matters relating to various portfolio companies of private equity funds. 

In addition to his practice, Mr. Goulding is engaged with a number of philanthropic organizations including the Make-A-Wish Foundation. He previously served as a board member of the United Way of Massachusetts and Merrimack Valley.

While in law school, Mr. Goulding served as editor-in-chief of the Villanova Law Review.

Mr. Goulding’s experience includes representing:

  • Altaris Capital in its sale of BK Medical
  • Drift in its strategic investment from Vista Equity Partners
  • Homology Medicines in its formation of AAV manufacturing and innovation business with Oxford Biomedica
  • Thomas H. Lee Partners and its portfolio companies in various transactions, including in its:
    • Investment in Ashling Partners
    • Take-private of Ceridian Corporation*
    • Acquisition of All Systems Holding*
    • Acquisition of Dayforce Corporation by its portfolio company Ceridian*
    • Recapitalization of MoneyGram International*
    • Corporate separation of Comdata and Ceridian HCM*
    • Sale of Comdata*
    • Sale of CompuCom Systems*
    • Sale of Intermedix Corporation*
    • Sale of LifeWorks Corporation*
    • Sale of Juvare*
    • Sale to SD Worx of Ceridian’s UK, Ireland and Mauritius subsidiaries*
    • Sale of an ethanol plant by Hawkeye Energy Holdings*
    • Sale with Summit Partners of Systems Maintenance Services*
    • Investment in Phytech*
    • Sale of System One*
  • Berkshire Partners and its portfolio companies, including in its:
    • Acquisition of the foodservice parts distribution and field service business assets of 3Wire Group*
    • Sale of Grocery Outlet to Hellman & Friedman*
    • Sale of National Vision to KKR*
    • Sale of HMT to Tailwind Capital*
    • Recapitalization of Masai Group International*
    • Investment in US Anesthesia Partners in a sizable minority*
    • Sale of SRS Distribution to Leonard Green & Partners*
  • Aquiline Capital Partners in its acquisition of Ontellus*
  • Froneri International (a joint venture between Nestlé and PAI Partners) in its acquisition of Dreyer’s Grand Ice Cream Holdings*
  • A&M Capital Europe and its portfolio company, Bolle Brands, in its take private of SPY Optic*
  • PSP Investments in its acquisition of significant timber assets in New Zealand*
  • Providence Equity Partners and its portfolio companies, including in its:
    • Provision of equity to Blackboard to finance Blackboard’s acquisition of Higher One Holdings*
    • Acquisition of a significant equity interest in RentPath*
    • Take-private of Blackboard*
    • Sale of certain television station assets owned by Newport Television*
    • Acquisition of ikaSystems Corporation and subsequent recapitalizations*
  • Providence Strategic Growth Partners in its investment in Burning Glass Technologies*
  • Partners Group in its sale of a controlling interest in Universal Services of America*
  • Francisco Partners in its:
    • Acquisition of Dynamo Software*
    • Acquisition of certain other subsidiaries and assets of Dynamo Group*
  • ICON Health & Fitness in connection with investments from Pamplona Capital Management and L Catterton*

*Matter handled prior to joining Latham

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.